期刊文献+

盐酸曲美他嗪在人体内药物动力学研究分析 被引量:4

Study and pharmacokinetic analysis of trimetazidine hydrochloride in human plasma
下载PDF
导出
摘要 目的建立液相色谱—串联质谱法(LC-MS/MS)测定血浆中盐酸曲美他嗪浓度的方法,并研究其药动学行为。方法选取我院2007年2月至2009年2月18名健康成年人作为药物试验对象,均单剂量口服盐酸曲美他嗪40mg后,采用液相色谱—串联质谱法(LC-MS/MS)测定血药浓度,应用AIC法判断房室模型,并利用DAS软件计算药动学参数。结果主要药动学参数:Cmax为(126.11±20.18)μg/L,tmax为(1.78±0.65)h,t1/2Ke为(5.87±0.79)h,Ke为(0.13±0.03)h,V/F为(4.00±0.59)L/kg,CL/F为(0.49±0.09)L.h-1.kg-1,AUC0-24为(1208.79±198.36)μg.h-1.L-1,AUC0-∞为(1304.46±224.13)μg.h-1.L-1。结论该分析方法简单、快速、准确、精密度高,适用于人体中盐酸曲美他嗪浓度的测定。盐酸曲美他嗪的血浆药动学参数与国内外文献报道基本一致。 Objective To establish an LC-MS/MS method for the determination of trimetazidine hydrochloride in human plasma,and to study its pharmacokinetics.Methods Volunteers received a single oral dose of 40mg trimetazidine hydrochloride tabletsand the plasma concent ration of trimetazidine hydrochloride was differentiated by LC-MS/MS method.The compartment model was differentiated by AIC method and DAS program was used to calculate the pharmacokinetic parameters.Results The drug to the main pharmacokinetic parameters:Cmax of(126.11±20.18)μg/L,tmax was(1.78±0.65)h,t1/2Ke of(5.87±0.79)h,Ke of(0.13±0.03)h,V/F was(4.00±0.59)L/kg,CL/F of(0.49±0.09)L·h-1·kg-1,AUC0-24 of(1208.79±198.36)μg·h-1·L-1,AUC0-∞ of(1304.46±224.13)μg·h-1·L-1.Conclusion The method is suitable to determine theconcent ration of trimetazidine hydrochloride in human plasma because it is rapid and sensitive.The pharmacokinetic parameters of trimetazidine hydrochloride are similar to those reports home and abroad.
出处 《中国现代医药杂志》 2011年第9期58-59,共2页 Modern Medicine Journal of China
关键词 盐酸曲美他嗪 液相色谱—串联质谱法(LC-MS/MS) 药动学 Trimetazidine hydrochloride LC-MS/MS Pharmacokinetics
  • 相关文献

参考文献3

二级参考文献14

  • 1赵锦国,张爱英,于志强.曲美他嗪治疗稳定型劳力性心绞痛患者疗效观察[J].中国新医药,2004,3(8):116-117. 被引量:3
  • 2Sentex E,Sergiel JP,Lucien A,et al.Is the cytoprofective effect of trimetazidine associated with lipid metabolism[J].Am J Cardiol,1998,82:18K-24K.
  • 3Mody FV,Singh BN,Mohiuddin IH,et al.Trimetazidine induced enhancement of myocardial glucose utilization in normal andischemic myocardial tissue:an evaluation by position emission tomography[J].Am J Cardiol,1998,82:42K-49K.
  • 4Krishnaiah YS,Karthikeyan RS,Bhaskar P,et al.Bioavailability studies on guar gum-based three-layer matrix tablets of trimetazidine dihydrochloride in human volunteers[J].J Control Release,2002,83:231-239.
  • 5McClellan KJ,Plosker GL.Trimetazidine:A review of its use in stable angina pectoris and other coronary conditions[J].Drugs,1999,58:143-157.
  • 6ChP.2005.vol Ⅱ (中国药典2005 年版.二部)[S]:appendix 173-176
  • 7MINK J,KYOUNG S K,CHANG S K,et al.An HPLC determination of trimetazidine in human plasma using liquid-liquid extraction for sample clean-up[J].J Liq Chrom Relat Tech,2005,28 (9):1299-1309.
  • 8SELLIER P,AUDOUIN P,PAYENL B,et al.Acute effects of trimetazidine evaluated by exercise testing[J].Eur J Clin Pharmacol,1987,33 (2):205-207
  • 9SIILYAKHTO E V,ALMAZOV V V A.Nifontov Evgeniy M,et al.Antianginal effects of trimetazidine and left ventricular function improvement in patients with stable angina pectoris[J].Am J Cardiovasc Drugs,2002,2(2):119-124.
  • 10YSR Krishnaiah, RS Karthikeyan, P Bhaskar, et al. Bioavailability studies onguar gumbased three-layer matrix tablets of trimetazidine hydrochloride in human volunteers[J]. Journal of Controllde Release, 83(202): 231-239.

共引文献15

同被引文献31

  • 1李玲珺,马鹏程,曹玉萍,陶蕾,魏峻.盐酸曲美他嗪健康人中的药动学研究和生物等效性评价[J].中国药师,2009,12(2):156-159. 被引量:4
  • 2焦阳,苏明明,陈闽军,贾伟,陶萍,仇益群,黄仲义.高效液相色谱/电喷雾质谱法测定血浆中曲美他嗪浓度[J].分析化学,2007,35(4):541-544. 被引量:2
  • 3邱相君,杨丽莉,石东恒,代宗顺.盐酸曲美他嗪片的人体生物等效性研究[J].中国药学杂志,2007,42(10):769-772. 被引量:4
  • 4刘玉旺,孙培红,周颖,赵东方,崔一民,赵侠.盐酸曲美他嗪片在健康人体的药代动力学[J].中国临床药理学杂志,2007,23(3):184-186. 被引量:6
  • 5邱相君,李艳,杨代正,王建刚,代宗顺.反相高效液相色谱法检测人血浆中盐酸曲美他嗪[J].药物分析杂志,2007,27(9):1364-1366. 被引量:2
  • 6ONAY-BESIKCI A, OZKAN SA. Trimetazidine revisited: a com-prehensive review of the pharmacological effects and analyticaltechniques for the determination of trimetazidine [ J ]. CardiovascTher, 2008,26(2) : 147 -165.
  • 7KRISHNAIAH YS, KARTHIKEYAN RS, BHASKAR P, et al.Bioavailability studies on guar gum-based three-layer matrix tab-lets of trimetazidine dihydrochloride in human volunteers [ J ]. JControl Release, 2002,83(2) : 231 - 239.
  • 8KHEDR A, SHEHA MM,DARWISH IA. Sensitive determina-tion of trimetazidine in spiked human plasma by HPLC with fluo-rescence detection after pre-column derivatization with 9-fluore-nylmethyl chloroformate [ J ]. J Chromatogr B Analyt Technol Bi-omed Life Sci , 2007,856(1 -2) : 337 -342.
  • 9BARRE J,LEDUDAL P, OOSTERHUIS B,et al. Pharmacoki-netic profile of a modified release formulation of trimetazidine(TMZ MR 35 mg) in the elderly and patients with renal failure[J]. Biopharm Drug Dispos, 2003 , 24(4) : 159 -164.
  • 10ZOU J, DAI L, WANG GJ, et al. Liquid chromatography-tan-dem mass spectrometry method for the determination of trimetazi-dine in human plasma [ J ]. Arzneimittelforschung, 2008 , 58(9):429 -434.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部